Julia Schleypen

Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

Julia Schleypen, Nicole Baur, Robert Kammerer et al. · Clinical Cancer Research · 2006 · 150 citations · Full text

Life Sciences, Immunology, Oncology +13

Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

Julia Schleypen, Marion von Geldern, Nicole Kotzias et al. · International Journal of Cancer · 2003 · 112 citations

Life Sciences, Immunology, Oncology +17

Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing

Kay Stubenrauch, Uwe Wessels, Herbert Birnboeck et al. · Clinical Therapeutics · 2010 · 70 citations

Life Sciences, Clinical Sciences, Immunology +17

Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies

Kay Stubenrauch, Uwe Wessels, Ulrich Essig et al. · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 56 citations

Life Sciences, Immunology, Pharmacology +10

The tumour suppressor gene <i>CEACAM1</i> is completely but reversibly downregulated in renal cell carcinoma

Robert Kammerer, Rainer Riesenberg, Christoph Weiler et al. · The Journal of Pathology · 2004 · 51 citations

Medicine, Immunology, Oncology +14